Lonza Group AG at JPMorgan Healthcare Conference Transcript
Welcome to the Lonza presentation at the 42nd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan. It's my great pleasure to introduce the CFO of Lonza, Philippe Deecke, who will give the presentation. After that, there will be a Q&A period. (Operator Instructions).
Philippe, welcome to the conference.
Thank you very much, Richard. Good afternoon, everyone. Great to see so many people joining us for the Lonza session, and great to be back at JPM to kickstart the year.
So we have about 40 minutes. I need to get that to work. So we have about 40 minutes together. So I will start by sharing an overview of our business and some insight into our unique position within the CDMO industry and why we believe we are well set up to capture the growth and value of this industry. We'll follow this by a closer look at our key priorities and divisional strategies and the attractive portfolio of organic
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |